We are live on ! Find out more
SGRY icon

Surgery Partners

168 hedge funds and large institutions have $5.98B invested in Surgery Partners in 2023 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 74 increasing their positions, 36 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more call options, than puts

Call options by funds: $24.4M | Put options by funds: $10M

106% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 36

86% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 21

33% more capital invested

Capital invested by funds: $4.48B → $5.98B (+$1.5B)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

11% more funds holding

Funds holding: 151168 (+17)

2.28% more ownership

Funds ownership: 102.91%105.2% (+2.3%)

Holders
168
Holders Change
+17
Holders Change %
+11.26%
% of All Funds
2.64%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
39
Increased
74
Reduced
36
Closed
21
Calls
$24.4M
Puts
$10M
Net Calls
+$14.4M
Net Calls Change
+$20M
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$14.3M +$7.33M +192,131 +153%
Bank of America
27
Bank of America
North Carolina
$14.1M +$176K +4,614 +1%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$13.5M +$2.4M +62,839 +27%
UBS AM
29
UBS AM
Illinois
$13.4M
PC
30
Pier Capital
Connecticut
$12.2M +$1.74M +45,532 +20%
IHAM
31
Integral Health Asset Management
New York
$11.2M +$4.88M +128,000 +105%
Adage Capital Partners
32
Adage Capital Partners
Massachusetts
$11.1M +$3.34M +87,510 +55%
Balyasny Asset Management
33
Balyasny Asset Management
Illinois
$10.1M +$7.21M +188,896 +516%
LCG
34
Lisanti Capital Growth
New York
$10.1M +$5.06M +132,545 +144%
AllianceBernstein
35
AllianceBernstein
Tennessee
$9.39M +$3.59M +94,014 +82%
CCP
36
Clough Capital Partners
Massachusetts
$9.08M +$1.99M +52,100 +35%
SBH
37
Segall Bryant & Hamill
Illinois
$8.83M +$34.6K +908 +0.5%
KCM
38
Kennedy Capital Management
Missouri
$8.05M +$3.41M +89,245 +99%
EAM
39
Eagle Asset Management
Florida
$7.97M -$199K -5,216 -3%
SGH
40
Sivik Global Healthcare
Connecticut
$7.87M
DCM
41
Dimension Capital Management
Florida
$7.25M
AAP
42
Ardsley Advisory Partners
Connecticut
$7.2M -$382K -10,000 -6%
Swiss National Bank
43
Swiss National Bank
Switzerland
$6.79M +$202K +5,300 +4%
CM
44
Castleark Management
Illinois
$6.34M +$5.38M +140,990 New
Citadel Advisors
45
Citadel Advisors
Florida
$5.5M -$5.7M -149,295 -55%
First Eagle Investment Management
46
First Eagle Investment Management
New York
$5.23M +$1.01M +26,500 +30%
BMSSC
47
B. Metzler seel. Sohn & Co
Germany
$4.98M +$2.25M +59,036 +115%
TI
48
Trexquant Investment
Connecticut
$4.96M -$1.18M -30,826 -22%
HIM
49
Hillsdale Investment Management
Ontario, Canada
$4.93M +$4.18M +109,580 New
RI
50
Redwood Investments
Massachusetts
$4.9M +$4.15M +108,818 New

SGRY Hedge Fund Activity: Q2 2023 in Review

168 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Surgery Partners (SGRY) for Q2 2023, worth a combined $5.98B — up 33% from $4.48B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new SGRY positions and 21 closed out — a net gain of 18 holders — while 74 added to existing stakes and 36 trimmed.

The largest buyer was BlackRock, adding an estimated $59.7M. The largest seller was Avidity Partners Management, cutting an estimated $68.7M.

  • 168 institutional investors held Surgery Partners (SGRY) as of Q2 2023, up from 151 in Q1 2023.
  • Funds reported $5.98B of Surgery Partners stock for Q2 2023, up 33% quarter-over-quarter.
  • 39 funds opened new Surgery Partners positions in Q2 2023 and 21 closed out, a net change of +18 holders.
  • The largest Surgery Partners buyer in Q2 2023 was BlackRock, an estimated $59.7M added.
  • The largest Surgery Partners seller in Q2 2023 was Avidity Partners Management, an estimated $68.7M sold.

Based on aggregated 13F filings for Q2 2023.